Direct effect of insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic beta cells

Diabetologia. 1990 Nov;33(11):649-53. doi: 10.1007/BF00400565.

Abstract

Purified pancreatic Beta cells were labelled with 3H-tyrosine before studying their secretory activity in perifusion. At 1.4 mmol/l glucose, the cells released similar fractions (0.01% per min) of their contents in preformed and in newly formed insulin. At 20 mmol/l glucose plus 10(-8) mol/l glucagon, these fractional release rates increased by 16 and 40-fold respectively. The preferential release of newly synthesized as compared to stored insulin is attributable to a heterogeneity in individual cell responses. The secretory responsiveness to glucose plus glucagon was completely suppressed by 10(-7) mol/l clonidine. Insulin induced a 20% reduction at 10(-6) mol/l, but remained without effect at 10(-7) mol/l. Insulin-like growth factor-I provoked a 30% decrease at 5.10(-9) mol/l. It is concluded that the type-I insulin-like growth factor receptors on pancreatic Beta cells mediate a suppressive action on the insulin release process. Their high affinity for insulin-like growth factor-I allows physiologic levels of this peptide to participate in the regulation of insulin release. Their low affinity for insulin provides the basis for a minor feedback action by this hormone at concentrations exceeding the normal circulating levels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Clonidine / pharmacology
  • Glucagon / pharmacology
  • Glucose / pharmacology
  • Insulin / metabolism
  • Insulin / pharmacology*
  • Insulin-Like Growth Factor I / pharmacology*
  • Islets of Langerhans / cytology*
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism
  • Male
  • Perfusion
  • Rats
  • Rats, Inbred Strains
  • Tritium

Substances

  • Insulin
  • Tritium
  • Insulin-Like Growth Factor I
  • Glucagon
  • Glucose
  • Clonidine